• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射给大鼠后,共价包被有ω-官能化表面活性剂的75Se放射性标记二氧化硅纳米颗粒在体内的分布。

Body distribution of 75Se-radiolabeled silica nanoparticles covalently coated with omega-functionalized surfactants after intravenous injection in rats.

作者信息

Borchardt G, Brandriss S, Kreuter J, Margel S

机构信息

Institut für Pharmazeutische Technologie, J.W. Goethe-Universität Frankfurt, Germany.

出版信息

J Drug Target. 1994;2(1):61-77. doi: 10.3109/10611869409015894.

DOI:10.3109/10611869409015894
PMID:8069585
Abstract

Silica nanoparticles, radiolabeled with 75Selenium were coated with 14 types of omega-functionalized surfactants covalently bound to the particle surface. The particles were suspended in phosphate buffered saline (PBS) and injected intravenously via the tail vein of Wistar rats. The animals were sacrificed after 5 different time points (30 min, 2 h, 6 h, 24 h, and 7 d), and two samples of each organ and two blood samples were weighed into vials. The radioactivity of each sample was measured in a LKB-Wallac CliniGamma counter. Coated silica nanoparticles accumulated in the liver at much lower levels than other colloidal drug carriers after short time periods (30 min). The liver accumulation increased after longer time periods due to a natural redistribution process. Surface modification by increasing the hydrophilicity and thickness of coating yielded higher and longer persisting concentrations in the intestine, blood, and the muscles. Initially increased lung concentrations were decreasing with time, probably due to migration of the alveolar phagocytes.

摘要

用75硒进行放射性标记的二氧化硅纳米颗粒,表面共价结合了14种ω-官能化表面活性剂。将这些颗粒悬浮于磷酸盐缓冲盐水(PBS)中,经尾静脉注射到Wistar大鼠体内。在5个不同时间点(30分钟、2小时、6小时、24小时和7天)后处死动物,将每个器官的两个样本和两份血液样本称重后放入小瓶中。每个样本的放射性在LKB - Wallac CliniGamma计数器中进行测量。在短时间(30分钟)后,包覆的二氧化硅纳米颗粒在肝脏中的蓄积水平远低于其他胶体药物载体。由于自然再分布过程,较长时间后肝脏蓄积增加。通过增加包衣的亲水性和厚度进行表面修饰,在肠道、血液和肌肉中产生了更高且持续时间更长的浓度。最初肺部浓度升高,但随时间下降,这可能是由于肺泡吞噬细胞的迁移所致。

相似文献

1
Body distribution of 75Se-radiolabeled silica nanoparticles covalently coated with omega-functionalized surfactants after intravenous injection in rats.静脉注射给大鼠后,共价包被有ω-官能化表面活性剂的75Se放射性标记二氧化硅纳米颗粒在体内的分布。
J Drug Target. 1994;2(1):61-77. doi: 10.3109/10611869409015894.
2
Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.
J Drug Target. 1993;1(1):15-9. doi: 10.3109/10611869308998760.
3
Influence of the surfactant concentration on the body distribution of nanoparticles.
J Drug Target. 1999;6(5):373-85. doi: 10.3109/10611869908996844.
4
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.用聚山梨酯80包被的聚(氰基丙烯酸正丁酯)纳米颗粒将他克林靶向递送至大脑。
Eur J Pharm Biopharm. 2008 Sep;70(1):75-84. doi: 10.1016/j.ejpb.2008.03.009. Epub 2008 Mar 27.
5
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.静脉注射后金纳米颗粒的粒径依赖性器官分布。
Biomaterials. 2008 Apr;29(12):1912-9. doi: 10.1016/j.biomaterials.2007.12.037. Epub 2008 Feb 1.
6
In vivo study on the biodistribution of silica particles in the bodies of rats.大鼠体内硅颗粒的生物分布体内研究。
Adv Clin Exp Med. 2012 Jan-Feb;21(1):13-8.
7
In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.表面改性二氧化硅纳米颗粒的体内生物分布及尿液排泄研究
Anal Chem. 2008 Dec 15;80(24):9597-603. doi: 10.1021/ac801882g.
8
Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles.用于去除表面活性剂以形成胶体介孔二氧化硅纳米粒子的透析过程。
Chem Commun (Camb). 2009 Sep 14(34):5094-6. doi: 10.1039/b908625k. Epub 2009 Jul 29.
9
Comparison of the kinetics of a trace and a sublethal dose of selenite in rats, with particular attention being given to blood selenium distribution.大鼠中痕量和亚致死剂量亚硒酸盐的动力学比较,尤其关注血液中硒的分布。
J Trace Elem Electrolytes Health Dis. 1991 Sep;5(3):155-64.
10
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.静脉注射后胶体金纳米颗粒的生物分布:粒径的影响。
Colloids Surf B Biointerfaces. 2008 Oct 15;66(2):274-80. doi: 10.1016/j.colsurfb.2008.07.004. Epub 2008 Jul 15.

引用本文的文献

1
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?工程介孔硅纳米粒子用于药物传递:二十年过去了,我们进展如何?
Chem Soc Rev. 2022 Jul 4;51(13):5365-5451. doi: 10.1039/d1cs00659b.
2
Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.纳米载体在脑癌治疗中吹响终场哨。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221080974. doi: 10.1177/15330338221080974.
3
Aerosol-synthesized siliceous nanoparticles: impact of morphology and functionalization on biodistribution.气溶胶合成的硅质纳米颗粒:形态和功能化对生物分布的影响。
Int J Nanomedicine. 2018 Nov 12;13:7375-7393. doi: 10.2147/IJN.S177350. eCollection 2018.
4
Preparation and Characterization of Double Shell FeO Cluster@Nonporous SiO@Mesoporous SiO Nanocomposite Spheres and Investigation of their Biocompatibility.双壳层FeO团簇@无孔SiO@介孔SiO纳米复合球体的制备、表征及其生物相容性研究
Iran J Biotechnol. 2015 Mar;13(1):1-10. doi: 10.15171/ijb.1068.
5
Nanoparticle Uptake: The Phagocyte Problem.纳米颗粒摄取:吞噬细胞问题。
Nano Today. 2015 Aug;10(4):487-510. doi: 10.1016/j.nantod.2015.06.006. Epub 2015 Sep 5.
6
Translational considerations for cancer nanomedicine.癌症纳米医学的转化考量。
J Control Release. 2010 Sep 1;146(2):164-74. doi: 10.1016/j.jconrel.2010.04.008. Epub 2010 Apr 10.
7
Photophysics of Cy3-encapsulated calcium phosphate nanoparticles.包裹Cy3的磷酸钙纳米颗粒的光物理学
Nano Lett. 2009 Apr;9(4):1559-66. doi: 10.1021/nl803658w.
8
The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.血清补体在静脉注射聚(甲基丙烯酸甲酯)纳米颗粒器官分布中的作用:血浆预包被和血清补体预包被的影响
Pharm Res. 1996 Jul;13(7):1055-8. doi: 10.1023/a:1016010808522.
9
Drug targeting with nanoparticles.
Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):253-6. doi: 10.1007/BF03188928.